iRhythm shares soar after FDA clears Zio AT device updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Boston Scientific (BSX) PT Raised to $98 at RBC Capital
October 24, 2024 6:37 AM EDTRBC Capital analyst Shagun Singh raised the price target on Boston Scientific (NYSE: BSX) to $98.00 (from $95.00) while maintaining a Outperform rating.
The analyst comments "BSX reported impressive Q3'24 results (+18% y/y organic or 1,120bps above end-markets, and 26% y/y EPS growth)... More
CL King Reiterates Buy Rating on Boston Scientific (BSX)
October 24, 2024 6:34 AM EDTCL King analyst Kristen Stewart reiterated a Buy rating and $90.00 price target on Boston Scientific (NYSE: BSX)
The analyst comments "Boston Scientific (BSX) reported 3Q24 results that came in well above consensus expectations. We expect the stock to react favorably to the... More
